Were you trying to imply the market capitalization should be worth 500million dollars plus by somewhere this year or by the time manufacturing begins, the rollout of merchandising of these new products began appearing on the shelves of pharmacies, or when revenue and some form of profit margins comes in?
Just to clarify, this is not including the valuation of the medical marijuana component which the company says they will be seriously looking into as a secondary revenue stream am I right?
News 
Market Data 
Discover 
AI
